In addition, we demonstrate that only 0.5% of all individuals referred for clinical genetic testing were found to have a BRCA1/2 AJ founder variant, while 8.5% had a PLPV in one of 41 actionable cancer risk genes. Here, BRCA1 is linked to cancer.